Sort
23,748 grants matching “melanoma”
Role for TbetaRIII Shedding in the Tumor Microenvironment
$327,599Gerard C Blobe · Duke University · R01 · FY2023 · CA
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
$327,598Markus H. Frank · Brigham And Women'S Hospital · R01 · FY2009 · CA
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$327,546Jun S Song · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
Classification of ambiguous melanocytic tumors
$327,526University Of California San Francisco · R33 · FY2004 · CA
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
$327,509Thomas B Tomasi · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Regulators of Melanocyte Stem Cell Migration and Melanoma Initiation in Response to Cutaneous UVB Irradiation
$327,498Andrew C White · Cornell University · R01 · FY2022 · AR
Large heat shock proteins and their role in cancer therapy
$327,475Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA
INTEGRATIVE GRAPHICAL MODELS FOR LARGE MULTI-MODAL BIOMEDICAL DATA
$327,472Panagiotis V Benos · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · LM
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside
$327,443Xianglin Shi · University Of Kentucky · R01 · FY2013 · ES
Targeting HSP70 in autoimmune vitiligo
$327,429Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2010 · AR
Occupational Safety and Health Research (R01)
$327,419Ellen Aura Eisen · University Of California Berkeley · R01 · FY2018 · OH
Occupational Safety and Health Research (R01)
$327,419Ellen Aura Eisen · University Of California Berkeley · R01 · FY2018 · OH
Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy
$327,396Brent Allen Hanks · Duke University · R37 · FY2023 · CA
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk
$327,375Anil Shanker · Meharry Medical College · SC1 · FY2020 · CA
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk
$327,375Anil Shanker · Meharry Medical College · SC1 · FY2019 · CA
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk
$327,375Anil Shanker · Meharry Medical College · SC1 · FY2017 · CA
FOCAL ADHESION KINASE--TUMOR BIOLOGY AND THERAPEUTICS
$327,375University Of Florida · R01 · FY2004 · CA
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk
$327,375Anil Shanker · Meharry Medical College · SC1 · FY2018 · CA
FOCAL ADHESION KINASE--TUMOR BIOLOGY AND THERAPEUTICS
$327,375University Of North Carolina Chapel Hill · R01 · FY2002 · CA
FOCAL ADHESION KINASE--TUMOR BIOLOGY AND THERAPEUTICS
$327,375University Of North Carolina Chapel Hill · R01 · FY2001 · CA
Targeting Lymphatic Vessels for Ligand Directed Imaging
$327,341Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA
TARGETING N-RAS AS A THERAPEUTIC APPROACH FOR MELANOMA
$327,333Trustees Of Boston University · · FY2012 · Department of the Army
Use of aAPC for melanoma adoptive immunotherapy
$327,299Jonathan P Schneck · Johns Hopkins University · R01 · FY2006 · CA
Anti-Cancer Activities of PTPase Inhibitors
$327,269Cleveland Clinic Foundation · R01 · FY2003 · CA
Effective surveillance strategies for melanoma patients
$327,232Janice N Cormier · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA